Revenue, 2025

USD 6.8 Billion

Forecast, 2035

USD 15.95 Billion

CAGR, 2026-2035

8.9%

Report Coverage

Global

qPCR Instruments Market Trends for 2026

The global qPCR instruments market size was estimated at USD 6.8 billion in 2025 and is predicted to increase from USD 7.41 billion in 2026 to approximately USD 15.95 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035. The rise in disease burden and growing R&D activities are increasing the use of qPCR instruments. Growing applications, expanding point-of-care testing trends, government initiatives, and new product launches are also enhancing the market growth.

Key Takeaways

• qPCR instruments sector pushed the market to USD 7.41 billion by 2026.
• Long-term projections show USD 15.95 billion valuation by 2035.
• Growth is expected at a steady CAGR of 8.9% in between 2026 to 2035.
• North America held the major revenue share of 38% of the global qPCR instruments market in 2025.
• Asia Pacific held 24% share of the market in 2025 and is expected to grow at the fastest CAGR of 10.5% during the forecast period.
• By product type, the instruments segment held a dominant revenue share of 42% of the market in 2025.
• By product type, the consumables & reagents segment is expected to grow at the fastest CAGR of 9.8% during the forecast period.
• By detection method type, the TaqMan probes segment held a dominant revenue share of 45% of the market in 2025 and is expected to grow at the fastest CAGR of 9.5% during the forecast period.
• By throughput type, the medium throughput segment held a dominant revenue share of 37% of the market in 2025.
• By throughput type, the high throughput segment held 35% of market share in 2025 and is expected to grow at the fastest CAGR of 10.2% during the forecast period.
• By application type, the clinical diagnostics segment held a dominant position in the market with a share of 48% in 2025 and is expected to grow at the fastest CAGR of 9.6% during the forecast period.
• By end user, the hospitals & diagnostic centers segment held a dominant revenue share of 40% of the qPCR instruments market in 2025.
• By end user, the pharmaceutical & biotechnology companies segment held 22% of market share in 2025 and is expected to grow at the fastest CAGR of 9.8% during the forecast period.

What are the qPCR Instruments?

The qPCR instruments market is driven by the rising prevalence of infectious diseases, the expansion of personalized medicines, and technological advancements. The qPCR instruments encompass the laboratory devices utilized for the amplification and measurement of DNA in real-time. These instruments are used for the detection and quantification of genetic materials, driving their demand across disease diagnosis, drug discovery and development, gene expression analysis, and food and environmental testing.

AI Technological Shifts in the qPCR Instruments Market

AI offers a wide range of applications in the qPCR instruments, driving their use for faster and more accurate results with reduced human errors. They offer automated data analysis and improved result interpretation, driving their use across complex sample analysis. Their stringent quality control, high-throughput data management, and multiplex assay optimization are also increasing their use for large-scale studies. It is also being used for drug target identification, biomarker discovery, and contamination control.

What are the Trends & Future Outlook of the qPCR Instruments Market?

Escalating Precision Medicine

The growing demand for precision or personalized medicines is increasing the use of qPCR instruments due to their accurate nucleic acid quantification, driving their use for biomarker discovery, functional genomics, and drug development.

Expanding Molecular Diagnostics

The growing incidences of infectious diseases and cancer are driving the demand for qPCR instruments, for early detection of infectious agents and genetic testing applications, where they are also being utilized as a routine diagnostic tool.

Blooming Technological Innovations

A rise in technological advancements is driving the development of new portable and miniaturized qPCR instruments with automation, high throughput systems, multiplexing capabilities, and cloud-based data management.

Quick Facts Table

Segmental Insights

By Product Type Insights

The Instruments Segment Dominated the Market With 42% in 2025

The instruments segment led the qPCR instruments market with 42% share in 2025, driven by growing focus on enhancing lab efficiency. This increased the adoption of advanced qPCR systems. Growth in decentralized testing also increased the demand for compact systems. Rising demand for automation in diagnostics has also increased the instrument sales.

The consumables & reagents segment is expected to witness the fastest growth with a CAGR of 9.8% during the forecast period, driven by high repeated usage. The growing diagnostic testing volumes are also increasing their demand. Additionally, expanding molecular testing is also increasing its consumption.

The software segment held 8% of the qPCR instruments market share in 2025, due to growing data analysis complexities. To enhance result accuracy and interpretation, AI-based analytics are also being utilized. The cloud-based integration is also being preferred to improve workflow efficiency.

By Detection Method Insights

The TaqMan Probes Segment Dominated the Market With 45% in 2025

The TaqMan probes segment accounted for the highest revenue share of 45% of the qPCR instruments market in 2025 and is expected to show the highest growth with a CAGR of 9.5% during the forecast period, driven by their high specificity. Their multiplexing capabilities also increased their use to enhance the testing workflows. Their expanding clinical applications also increased their acceptance rates.

The SYBR green segment held 35% of the qPCR instruments market share in 2025, due to its affordability. Their simplicity also contributed to their increased usability. The growth in the general gene expression studies also increased their use.

The molecular beacons segment held 12% of the market share in 2025, due to their high sensitivity, which increased their use in niche diagnostic applications. Enhanced probe design also increases the acceptance rates. Their growing use in mutation detection is also driving their adoption rates.

The others (scorpions, FRET probes) segment held 8% of the market share in 2025, driven by their specialized applications. Expanding technological innovation is also increasing its use across various niche areas. Additionally, growing R&D activities are also increasing their adoption rates.

By Throughput Insights

The Medium Throughput Segment Dominated the Market With 37% in 2025

The medium throughput segment held a major revenue share of 37% of the qPCR instruments market in 2025, due to their balanced cost and efficiency, which increased their adoption across mid-sized labs. Enhanced flexibility also increased their use for various applications. Growth in diagnostic volume also increased their use.

The high throughput segment held 35% of the market share in 2025 and is expected to expand rapidly with a CAGR of 10.2% during the forecast period, due to growing demand for automation for large-scale testing. Expanding pharmaceutical R&D activities are also increasing their use. Additionally, growing focus on pandemic preparedness is also increasing the adoption rates.

The low-throughput segment held 28% of the qPCR instruments market share in 2025, driven by their affordability, increasing their use across small labs. They are also preferred for limited sample processing. Moreover, they are also being used for academic research applications.

By Application Insights

The Clinical Diagnostics Segment Dominated the Market With 48% in 2025

The clinical diagnostics segment contributed the biggest revenue share of 48% of the qPCR instruments market in 2025 and is expected to show the highest growth rate with a CAGR of 9.6% during the forecast period, driven by growth in infectious disease burden. Growth in government screening programs also increased the demand for qPCR instruments. Additionally, increasing demand for personalized medicines has also increased their use for molecular diagnostics.

The research applications segment held the second-largest share of 32% of the market in 2025, due to increasing gene expression studies and genomic research. Growing cancer and infectious disease research is also increasing the use of qPCR instruments. The rise in academic funding is also increasing their adoption rates.

The food & environmental testing segment held 12% of the qPCR instruments market share in 2025, driven by stringent food safety regulations. This is increasing the use of qPCR instruments for the detection of pathogens in the food supply chain. Expanding focus on environmental monitoring is also increasing its use.

The forensic testing segment held 8% of the market share in 2025, due to DNA profiling applications. The qPCR instruments are also being used for criminal investigations. Additionally, growing government investments are also driving their adoption rates across forensic labs.

By End User Insights

The Hospitals & Diagnostic Centers Segment Dominated the Market With 40% in 2025

The hospitals & diagnostic centers segment held the largest revenue share of 40% of the qPCR instruments market in 2025, driven by growth in the patient volume. Expansion of hospital labs' support also increased the adoption of qPCR instruments. Focus on quality care also increased their use of molecular diagnostics.

The academic & research institutes segment held 25% of the qPCR instruments market share in 2025, due to expanding genomic studies. Growing government funding is also promoting the qPCR instruments adoption rates. Additionally, growing collaborations are also increasing their use.

The pharmaceutical & biotechnology companies segment held 22% of the market share in 2025 and is expected to show the fastest growth with a CAGR of 9.8% during the forecast period, driven by expanding R&D activities and increasing demand for gene analysis tools. Growing biotech innovation is also increasing qPCR instruments adoption rates. Expanding clinical trials are also increasing their adoption rates.

The contract research organizations (CROs) segment held 13% of the market share in 2025, due to their affordable services. The growing outsourcing trends are also increasing their use to leverage advanced qPCR instruments. Expanding clinical trials are also increasing their collaborations.

Regional Insights

Well-developed Healthcare Drives North America

North America registered its dominance over the global qPCR instruments market with 38% in 2025, due to the presence of advanced healthcare infrastructure and robust key players, which contributed to the increased qPCR instruments innovations. High infectious disease burden and diagnostic testing rates also increased their adoption. Growth in R&D activities also enhanced the market growth.

U.S. Market Trends

The U.S. consists of robust companies driving the development of new qPCR instruments. Large-scale diagnostics and R&D investments are also boosting their usage. The presence of a strong R&D ecosystem and healthcare infrastructure is also increasing their use for disease diagnosis, genomics, and drug discovery applications.

Rapid Healthcare Expansion Boost Asia Pacific

Asia Pacific held 24% share of the qPCR instruments market in 2025 and is expected to grow at the fastest CAGR of 10.5% during the forecast period, due to rapid healthcare expansion and growing disease burden. The expanding molecular testing infrastructure and government initiatives are also increasing the adoption of the qPCR instruments. Increasing health awareness is also increasing their use, promoting market growth.

China Market Trends

The expanding pharmaceutical and biotechnology sector in China is increasing the demand for qPCR instruments, where the large population is also driving their use for early and accurate disease detection. The growing government initiatives are also accelerating their adoption rates and innovations. Growing genomics research is also increasing its adoption rates.

qPCR Instruments Market Value Chain Analysis

R&D

• The R&D of the qPCR instruments focuses on the integration of vapor chamber cooling technology, extreme multiplexing, and AI-driven automated data analysis.
• Key players: Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics.

Clinical Trials and Regulatory Approvals

• The analytical sensitivity, reproducibility, and clinical specificity are evaluated in the clinical trials and regulatory approval of the qPCR instruments.
• Key players: Bio-Rad Laboratories, Roche Diagnostics, Cepheid.

Patient Support and Services

• Rapid diagnostic screening services, educational resources, and comprehensive technical assistance are provided in the patient support and services of the qPCR instruments.
• Key players: Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics.

Who are the qPCR Instruments Market Top Vendors and What are Their Offerings?

SWOT Analysis

Strengths

• The qPCR instruments offer high sensitivity and specificity, which increases their use for DNA or RNA detection.
• They also provide quantitative results, promoting their use for real-time analysis.
• Their rapid results and high reproducibility are also increasing their demand.
• Their wide range of applications also drives their demand for diagnostics, forensics, research, and food testing.

Weaknesses

• High costs associated with qPCR instruments and reagents act as the major weakness in the qPCR instruments market, limiting their adoption rates.
• Technical complexities also increase the need for trained personnel, reducing their use.

Opportunities

• Growing infectious disease burden is driving the demand for qPCR instruments.
• Expanding genomic research is also increasing its use.
• Growing focus on precision medicine and food safety is also increasing their adoption rates.
• Growing R&D activities and technological advancements are also driving their use and innovations.

Threats

• Rapid technological advancements limit the innovations of the qPCR instruments.
• Stringent quality control and reliance on specialized reagents also slow down their innovations.

What are the Recent Developments in the qPCR Instruments Market?

• In April 2025, for the detection of hypermutated phenotype associated with mutations in POLD1 and POLE in endometrial cancer, Idylla, which is a fully automated, real-time quantitative polymerase chain reaction (qPCR) assay, was launched by Biocartis, where it detects 1 mutation in the POLD1 gene and 17 point mutations in the POLE gene.
• In September 2024, an automated, high-throughput qPCR solution, the SmartChip ND™ Real-Time PCR System, for research-use-only (RUO) monitoring antimicrobial resistance (AMR) and ensuring environmental safety and sustainability, was launched by Takara Bio USA, Inc.

Segments Covered in the Report

By Product Type

• Instruments
  • Benchtop qPCR Systems
  • Portable/Compact qPCR Systems
• Consumables & Reagents
• Assays & Kits 
  • Gene Expression Kits
  • Pathogen Detection Kits
  • SNP Genotyping Kits
• Master Mixes
• Plates & Tubes
• Software
  • Data Analysis Software
  • Cloud-based Platforms

By Detection Method

• SYBR Green
• TaqMan Probes
• Molecular Beacons
• Others (Scorpions, FRET Probes)

By Throughput

• Low Throughput
• Medium Throughput
• High Throughput

By Application

• Clinical Diagnostics
  • Infectious Diseases
  • Oncology
  • Genetic Testing
• Research Applications
  • Gene Expression Analysis
  • Genomics & Proteomics
• Forensic Testing
• Food & Environmental Testing

By End User

• Hospitals & Diagnostic Centers 
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs) 

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA